Pharma Talks

Pharma Talks

di Nataliya Andreychuk
MarketingTecnologia
The Impact of AI on Jobs l Pharma Talks with Nataliya Andreychuk
Karol Wolak, Director and Global Omnichannel Excellence Lead at Merck, joins Nataliya Andreychuk on Pharma Talks to tackle a question on everyone's mind: is AI coming for pharma jobs? His perspective is grounded in hands-on work across customer engagement and digital transformation at one of the industry's largest organizations. Views shared are Karol Wolak's own and do not represent an official position of Merck. Key takeaways: AI isn't replacing pharma roles anytime soon — it's better positioned to absorb repetitive back-office work like content tagging, MLR approval, and data collection. Human qualities — context, ethics, judgment, empathy — remain outside what AI can deliver, especially in a highly regulated industry. The environmental cost of AI, from data storage to energy consumption, is a factor the industry rarely puts on the table. Patient-centricity stays the anchor point for every engagement decision, regardless of which technology sits behind it. Staying engaged and experimenting with AI beats waiting on the sidelines — but balance matters more than volume. Chapters: 0:00 Cold open — "AI will not replace us, at least not now" 0:51 Karol Wolak on the shift from multichannel to omnichannel at Merck 1:49 Why patients are the real center of pharma engagement 3:33 Does AI take our jobs? The blunt answer 5:02 Resource optimization: where AI actually helps pharma teams 7:14 The environmental cost of AI no one talks about 9:18 Finding the balance between innovation and human survival 13:06 Advice for listeners: don't wait on the sidelines 📲 Enjoyed this episode? 👉 Like, Subscribe & hit the 🔔 to never miss a Pharma Talks episode 👉 Want to be a guest? Plan your recording with Nataliya Andreychuk at NEXT Pharma Summit (Dubrovnik) 🔗 Follow & Connect: 🎙️ Nataliya Andreychuk → https://www.linkedin.com/in/andreychuk/ 🎙️ Karol Wolak → https://www.linkedin.com/in/karolwolak/
22 lug 2026
15:50
Agentic AI in Pharma: Are We Ready for AI That Acts? l Pharma Talks with Nataliya Andreychuk
Agentic AI has moved pharma from answering questions to autonomously orchestrating entire workflows — but most organisations are still building the foundations it needs to run well. In this episode, Nataliya Andreychuk talks with Michal Dojlidko about what agentic AI actually requires in practice: the right data, the right guardrails, continuous upskilling, and a clear-eyed view of where humans still belong in the loop. Key topics Evolution of AI in pharma from answering questions to autonomous workflows Importance of trust and data foundations in AI adoption Regulatory considerations and human oversight in agentic AI Future roles of humans as strategists and overseers of AI Technological advancements enabling secure, scalable AI solutions Chapters 00:00 Introduction to Agentic AI in Pharma Marketing 00:55 Evolution of AI in Pharma 02:34 The Shift to Autonomous AI 03:49 Reimagining Workflows with AI 05:10 Building Trust in AI 06:23 Data Foundations for AI Success 07:47 Continuous Learning and AI Literacy 09:31 The Future Role of Humans in AI 12:19 Security and Compliance in AI 14:11 Human Oversight in Regulated Industries 15:56 Hot or Not: AI Statements 23:45 Conclusion and Key Takeaways Discover more platforms to listen to this podcast: https://rss.com/podcasts/pharma-talks/ *** Follow Viseven, Nataliya, and Michal in social media: https://www.linkedin.com/company/2907491 https://www.linkedin.com/in/andreychuk/ https://www.linkedin.com/in/mdojlidko/
17 lug 2026
24:48
How to Build an Omnichannel Strategy in Pharma l Pharma Talks with Nataliya Andreychuk
Michael Kirzhner, Omnichannel Platforms and Capabilities Leader at AbbVie, joins Nataliya Andreychuk to discuss the real state of omnichannel in pharma — what the industry has built, what's still missing, and where the next evolution lies. Michael has spent over a decade navigating the shift from field-centric models to digital-first orchestration inside one of the world's largest pharma companies. In this episode: Omnichannel fragmentation starts with departments, not technology — the coordination layer is what pharma hasn't built yet Most companies are strong at functional execution but lack a central decisioning function that cuts across channels Digital opinion leaders are outpacing traditional KOLs because they've mastered the channels pharma is still learning Patient services is facing the same orchestration challenge commercial solved — and the stakes are higher AI's real value isn't automation — it's closing the gaps in personalization, decisioning, and content throughput that were previously impossible at scale 📲 Enjoyed this episode? 👉 Like, Subscribe & hit the 🔔 to never miss a Pharma Talks episode 👉 Want to be a guest? Plan your recording with Nataliya Andreychuk at NEXT Pharma Summit (Dubrovnik) 🔗 Follow & Connect: 🎙 Nataliya Andreychuk → https://www.linkedin.com/in/andreychuk/ 🎙 Michael Kirzhner → https://www.linkedin.com/in/michaelkirzhner/
8 lug 2026
40:38
Pharma Talks with Nataliya Andreychuk | Live from NEXT Pharma Summit | Jennifer Cleall
In this episode of Pharma Talks, recorded live at NEXT Pharma Summit in Dubrovnik, Nataliya Andreychuk speaks with Jennifer Cleall, Global Head of Digital Transformation at Ferring Pharmaceuticals, on what it actually takes to align medical and commercial teams — and where AI fits into that picture. Jennifer brings cross-industry perspective spanning pharma, med tech, and enterprise technology. Key takeaways: AI won't take our jobs — but being deliberate about where and why you apply it is what separates progress from noise Before layering in AI, organizations need to simplify processes and systems first — technology won't fix broken foundations AI can act as an enabler for medical-commercial alignment, but directional clarity on where you're headed has to come first The goal hasn't changed: showing up with relevance and trust for HCPs to improve patient outcomes Digitizing what exists today is not the destination — the real question is where pharma needs to be in five to ten years 📲 Enjoyed this episode? 👉 Like, Subscribe & hit the 🔔 to never miss a Pharma Talks episode 👉 Want to be a guest? Plan your recording with Nataliya Andreychuk: https://www.linkedin.com/in/andreychuk/
2 lug 2026
5:05
Breaking Pharma Silos: Strategies for Cross-Functional Success l Pharma Talks
In this episode Laragh De Bhulbh shares her expertise on breaking down silos within pharma organizations, fostering cross-functional collaboration, and implementing strategic frameworks to enhance medical affairs. Discover practical tips for leaders and the importance of trust, communication, and strategic alignment in driving patient impact. Key topics: - Cross-functional collaboration challenges in pharma - The Catalyst framework for alignment - Leadership strategies for medical affairs - The role of trust and communication Chapters 00:00 Introduction to Laragh De Bhulbh and her expertise 01:24 Lara's background and motivation for improving pharma collaboration 02:21 The evolution of medical affairs and organizational alignment 03:27 Challenges in integrating medical and commercial functions 06:10 Overcoming silos: trust, safety, and open communication 10:04 The Catalyst framework: eight pillars for cross-functional success 12:42 The importance of omnichannel communication and rapid pivoting 15:59 Leadership tips for fostering collaboration and strategic clarity 17:43 Quick reactions: what is hot or not in pharma collaboration 19:18 Final thoughts: clarity and communication as game changers Discover more platforms to listen to this podcast: https://rss.com/podcasts/pharma-talks/ *** Follow Viseven, Nataliya, and Laragh in social media: https://www.linkedin.com/company/2907491 https://www.linkedin.com/in/andreychuk/ https://www.linkedin.com/in/ldeb/
24 giu 2026
19:48
Pharma Talks with Nataliya Andreychuk | Live from NEXT Dubrovnik | Michael Kurr
In this episode of Pharma Talks, recorded live at NEXT Pharma Summit in Dubrovnik, Nataliya Andreychuk speaks with Michael Kurr, a global transformation leader with 15+ years building large-scale commercial and medical affairs operations at Novartis and Boehringer Ingelheim, on what delivery at scale actually looks like in the AI era. Michael built content and delivery organizations of over 1,000 people — and he has some of the most direct takes on where pharma transformation is stalling. Key takeaways: Modular content served its purpose as a scalability crutch — but well-trained AI models will eventually make it obsolete MLR is a bottleneck not just because of technology, but because of trust — local approvers carry legal liability and need confidence in what they sign off AI systems must become more explainable and deterministic before pharma can rely on AI-generated and AI-approved content The King Kong principle: having content is the easier part — getting the right content to the right customer at the right time, at scale, is the real challenge Staying relevant and staying current is the only viable strategy for individuals navigating AI-driven transformation 📲 Enjoyed this episode? 👉 Like, Subscribe & hit the 🔔 to never miss a Pharma Talks episode 👉 Want to be a guest? Plan your recording with Nataliya Andreychuk at NEXT Pharma Summit (Dubrovnik) 🔗 Follow & Connect: 🎙️ Nataliya Andreychuk → https://www.linkedin.com/in/andreychuk/ 🎙️ Michael Kurr → https://www.linkedin.com/in/michaelkurr/
17 giu 2026
14:37
Pharma Talks with Nataliya Andreychuk | Live from NEXT Dubrovnik | Lauren Leahy
In this episode of Pharma Talks, recorded live at NEXT Pharma Summit in Dubrovnik, Nataliya Andreychuk speaks with Lauren Leahy, who leads global and international medical capabilities operations, on what AI really means for the people working inside pharma today. Lauren brings a medical affairs perspective to a conversation that's usually dominated by commercial voices. Key takeaways: AI isn't eliminating jobs — but it is fundamentally changing how they're structured and what skills they demand In omnichannel, AI is actually increasing workload in the short term as teams redesign processes and upskill The real opportunity isn't just productivity gains — it's system-level change and improved output quality Medical and commercial functions need to work closer together around a single customer experience Staying curious and adaptable — at both individual and company level — is the core competency for navigating what's ahead 📲 Enjoyed this episode? 👉 Like, Subscribe & hit the 🔔 to never miss a Pharma Talks episode 👉 Want to be a guest? Plan your recording with Nataliya Andreychuk 🔗 Follow & Connect: 🎙️ Nataliya Andreychuk → https://www.linkedin.com/in/andreychuk/
5 giu 2026
3:14
Pharma Talks with Nataliya Andreychuk | Live from NEXT Dubrovnik | Laetitia Huret
In this episode of Pharma Talks, recorded live at NEXT Pharma Summit in Dubrovnik, Nataliya Andreychuk sits down with Laetitia Huret, Lead of Transformation at Servier, to explore what AI-driven commercial excellence actually looks like on the ground. Laetitia Huret works across global-to-local transformation, helping teams navigate digital, data, and AI change in the sales and commercial space. Key takeaways: The real question isn't whether AI will replace jobs — it's whether we're willing to keep ways of working that can be replaced AI's value in pharma lies in augmenting HCP engagement, not just accelerating content volume Human experience and accumulated knowledge remain the irreplaceable edge in an AI-assisted environment Embracing agentic and generative AI tools requires genuine investment in understanding them — not expecting magic Those not actively adopting AI risk falling behind in an industry-wide shift already underway 📲 Enjoyed this episode? 👉 Like, Subscribe & hit the 🔔 to never miss a Pharma Talks episode 👉 Want to be a guest? Plan your recording with Nataliya Andreychuk 🔗 Follow & Connect: 🎙️ Nataliya Andreychuk → https://www.linkedin.com/in/andreychuk/
4 giu 2026
5:58
Pharma Talks: AI in Pharma Communication – Breaking the Myths, Navigating Asia l Part 2
Watch the first part of the conversation: https://youtu.be/PtR62juQ4FY This episode Nataliya Andreychuk with guests explores the impact of AI on pharma marketing and communication, emphasizing the importance of human oversight, regional differences in Asia, and practical strategies for global-to-local adaptation. 👥 Guests in this episode: Bruno Senouci - co-CEO at DRCOM Gwenael Meneux - co-CEO at DRCOM Key Topics: AI impact on pharma communication Regional differences in Asia healthcare markets Global to local content adaptation strategies Contact Viseven experts to elevate your healthcare marketing strategy: https://viseven.com/contact-us/ Follow Viseven and Nataliya, Bruno and Gwenael in social media: https://www.linkedin.com/in/andreychuk/ https://www.linkedin.com/in/bsenouci/ https://www.linkedin.com/in/gwenael-meneux/?locale=fr
3 giu 2026
19:00
Pharma Talks: AI in Pharma Communication – Breaking the Myths, Navigating Asia l Part 1
Watch the second part of the conversation: https://youtu.be/9wQPF4W6qNQ This episode Nataliya Andreychuk with guests explores the impact of AI on pharma marketing and communication, emphasizing the importance of human oversight, regional differences in Asia, and practical strategies for global-to-local adaptation. 👥 Guests in this episode: Bruno Senouci - co-CEO at DRCOM Gwenael Meneux - co-CEO at DRCOM Key Topics: AI impact on pharma communication Regional differences in Asia healthcare markets Global to local content adaptation strategies Follow Viseven and Nataliya, Bruno and Gwenael in social media: https://www.linkedin.com/in/andreychuk/ https://www.linkedin.com/in/bsenouci/ https://www.linkedin.com/in/gwenael-meneux/?locale=fr
26 mag 2026
19:47
1 di 5